Test Discontinuation Memorandum

Effective May 9, 2016, Baylor Miraca Genetics Laboratories (BMGL) will discontinue the following tests:

  • Test code 6055 – Spinocerebellar Ataxia Type 10 Repeat Expansion Analysis
  • Test code 6054 – Spinocerebellar Ataxia Type 1 Repeat Expansion Analysis
  • Test code 6027 – DRPLA Repeat Expansion Analysis
Previous Post
Shashikant Kulkarni joins as senior Vice President of Lab Operations, Chief Science Officer
Next Post
Test Updates Memorandum – Mitochondrial
Menu